DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Jiang LBD, Yoon YJ, Chou H. , et al.
Significant anti-fibrotic efficacy of EDP-305, a highly potent and selective farnesoid X receptor (FXR) agonist, in a rat model of thioacetamide-induced liver fibrosis and cirrhosis.
2017, Washington, DC: AASLD Annual Meeting; 2017
Access:
We do not assume any responsibility for the contents of the web pages of other providers.